CTRI/2024/03/064417Not yet recruitingUnknown
To assess the efficacy and safety of probing of nasolacrimal duct with Mitomycin-C in adults with primary acquired nasolacrimal duct obstruction. - nil
Dr Vandana Sharma0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •patients having a history of primary epiphora due to NLDO
- •patients who will give written consent for the procedure.
Exclusion Criteria
- •Patient with history of previous trauma, recurrent dacryocystitis, surgery, any other obvious cause for NLDO.
- •Any ocular disease leading to hyper-lacrimation such as dry eye, corneal ulcer, ocular foreign bodies, etc.
- •Pregnant women and women who will be planning to become pregnant within the next 6 months.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Safety and efficacy assessment of products on skin.CTRI/2021/02/031386Alaina Healthcare Pvt Ltd
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Adjustable-depth fractional microneedle bipolar radiofrequency in Treatment of Wrinkle and Neck ContouringHealthy PatientAdjustable-depth fractional microneedle bipolar radiofrequency,Wrinkle and Neck ContouringTCTR20230403002ASTRACO MEDICAL NETWORKS LTD.27
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Adjustable-depth fractional microneedle bipolar radiofrequency in Treatment of Wrinkle and Facial ContouringTCTR20230331003ASTRACO MEDICAL NETWORKS LTD.28
Not yet recruiting
Unknown
Safety and Efficacy check of Cosmetic Product on skiCTRI/2024/01/061433KAYA LIMITED
Not yet recruiting
Unknown
Efficacy check of skin care productCTRI/2023/12/060574SATIYA NUTRACEUTICALS PRIVATE LIMITED